Atossa Genetics (ATOS)
(Delayed Data from NSDQ)
$1.49 USD
-0.20 (-11.83%)
Updated May 10, 2024 04:00 PM ET
After-Market: $1.44 -0.05 (-3.36%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Brokerage Reports
Atossa Genetics Inc. [ATOS]
Reports for Purchase
Showing records 1 - 20 ( 57 total )
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
EVANGELINE Data From 40 mg Z-Endoxifen Dose Increase Our Confidence in 80 mg Dose
Provider: H.C. Wainwright & Co., Inc.
Analyst: BODNAR E
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
4Q23 Recap: Two Key Z-Endoxifen Data Readouts Expected in 2H24
Provider: H.C. Wainwright & Co., Inc.
Analyst: BODNAR E
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Spotlighting Tamoxifen''s Active Metabolite, Endoxifen, as a Standalone and Superior Drug; Initiating at Buy and $4 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BODNAR E
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Multiple opportunities to address breast health
Provider: Edison Investment Research Limited
Analyst: HEMAMI P
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Atossa raises $13.4m in rights offering
Provider: EDISON INVESTMENT RESEARCH LIMITED
Analyst: HEMAMI P
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Atossa raises $13.4m in rights offering
Provider: EDISON INVESTMENT RESEARCH LIMITED
Analyst: HEMAMI P
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Adjusting price target to $4.50 following results, split, and capital raising activities
Provider: SEETHRUEQUITY, LLC
Analyst: TANDON A
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
We initiate coverage on Atossa Genetics with a price target of $1.15 per share
Provider: SEETHRUEQUITY, LLC
Analyst: TANDON A